Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -309,851 | -306,735 | -314,248 | -181,223 | 29,403 |
| Depreciation Amortization | 224,807 | 13,694 | 17,074 | 15,596 | 9,326 |
| Income taxes - deferred | -205 | -11,424 | N/A | -93,649 | N/A |
| Accounts receivable | 9,091 | -17,829 | 5,455 | -7,166 | -1,603 |
| Accounts payable and accrued liabilities | 1,405 | 206 | 1,025 | 6,363 | -5,072 |
| Other Working Capital | -40,578 | -58,957 | -53,972 | 20,327 | -3,286 |
| Other Operating Activity | -90,727 | 121,872 | 81,455 | 128,572 | -9,265 |
| Operating Cash Flow | $-206,058 | $-259,173 | $-263,211 | $-111,180 | $19,503 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 130,192 | 13,549 | 133,012 | -352,807 | -218,283 |
| PPE Investments | -6,188 | -8,843 | -16,750 | -5,931 | -1,039 |
| Net Acquisitions | N/A | -102 | N/A | -319,793 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -179 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -179 | 0 | 0 |
| Investing Cash Flow | $124,004 | $4,604 | $116,083 | $-678,531 | $-219,322 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 895,536 | N/A |
| Debt Repayment | -490 | -1,842 | -1,608 | -361 | -16,000 |
| Common Stock Issued | 7,703 | 204,519 | 11,230 | 326,651 | 233,839 |
| Other Financing Activity | -50,200 | -93,786 | 0 | -52,245 | 34,000 |
| Financing Cash Flow | $-42,987 | $108,891 | $9,622 | $1,169,581 | $251,839 |
| Beginning Cash Position | 182,633 | 328,311 | 465,817 | 85,947 | 33,927 |
| End Cash Position | 57,592 | 182,633 | 328,311 | 465,817 | 85,947 |
| Net Cash Flow | $-125,041 | $-145,678 | $-137,506 | $379,870 | $52,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206,058 | -259,173 | -263,211 | -111,180 | 19,503 |
| Capital Expenditure | -6,188 | -8,843 | -16,750 | -5,931 | -1,039 |
| Free Cash Flow | -212,246 | -268,016 | -279,961 | -117,111 | 18,464 |